By futureTEKnow | Editorial Team
The landscape of space manufacturing is rapidly evolving, and few companies are pushing the boundaries quite like Varda Space Industries. In a recent interview, Varda’s CEO Will Bruey and co-founder Delian Asparouhov offered a rare glimpse into their ambitious plans following a major Series C funding round. Their mission? To revolutionize pharmaceutical manufacturing in low Earth orbit—and, in the process, reshape how we think about both medicine and aerospace technology.
“Microgravity allows us to create new drug formulations that otherwise would be impossible to create on Earth. That’s the whole purpose of Varda.” — Will Bruey
At the heart of Varda’s strategy is the unique environment of microgravity. On Earth, gravity limits the ways molecules can interact, often restricting the complexity or purity of pharmaceutical compounds. In orbit, however, microgravity enables the creation of medicines with properties and effectiveness that simply can’t be replicated on the ground. This opens the door to entirely new classes of drugs—a game-changer for biotech and healthcare.
With fresh capital, Varda is expanding its biologics lab to prepare and vet drug formulations before sending them to space. The company is moving away from relying on third-party launch providers and is now internalizing its manufacturing and launch cadence. This shift means:
More frequent launches: Varda plans to quadruple its flight rate next year, with ambitions to double that cadence annually.
Full control over the supply chain: Owning more of the process allows for greater flexibility and innovation in biopharmaceutical production.
Lower costs and higher reliability: Operating smaller, non-human-rated reentry vehicles keeps costs down and increases mission frequency.
One of the most technically demanding aspects of Varda’s operation is returning payloads from orbit. Their spacecraft reenters Earth’s atmosphere at Mach 25—about 25 times the speed of sound—creating a spectacular plasma trail as it streaks across the sky. This high-speed reentry is not just a spectacle; it’s a crucial phase for safely delivering space-manufactured pharmaceuticals back to Earth.
Varda’s technology isn’t just about medicine. The U.S. Department of Defense and other government agencies are keenly interested in the company’s capabilities. Varda’s reentry vehicles function as hypersonic wind tunnels, allowing the military to test new materials, sensors, and navigation systems under extreme conditions—faster and more affordably than traditional methods. This helps the U.S. keep pace with, and potentially surpass, near-peer competitors in hypersonic technology.
Unlike larger players such as SpaceX or Boeing, Varda’s vehicles are smaller, higher cadence, and not designed for human passengers. This makes them uniquely suited for frequent, cost-effective missions focused on manufacturing and research, rather than transporting astronauts. The main challenge ahead? Scaling up launch frequency to meet the growing demand from the pharmaceutical industry, which cares less about the journey and more about the quality and novelty of the drugs delivered.
Varda’s rise is made possible by advances in reusable rocket technology, notably SpaceX’s Falcon 9. The availability of regular, affordable launches has created a new infrastructure layer—much like the mobile app store did for Uber and Airbnb—enabling entirely new business models in space.
In the long term, pharmaceutical companies stand to gain the most from Varda’s innovations, integrating space-manufactured drugs into the global supply chain. Meanwhile, the defense sector benefits from rapid, real-world testing of next-generation aerospace technologies. With its fleet of small, high-frequency reentry vehicles, Varda is poised to serve both markets as a critical infrastructure provider for the new space economy.
futureTEKnow is a leading source for Technology, Startups, and Business News, spotlighting the most innovative companies and breakthrough trends in emerging tech sectors like Artificial Intelligence (AI), immersive technologies (XR), robotics, and the space industry. Since 2018, futureTEKnow has evolved from a social media platform into a comprehensive global database and news hub, delivering insightful content that connects entrepreneurs, investors, and industry professionals with the latest advancements shaping the future of business and technology.
Microsoft is investing $4 billion in Elevate, aiming to train 20 million people worldwide in AI skills. The program offers accessible education, credentials, and global partnerships to prepare the workforce for an AI-driven future.
Discover how the AI boom is pushing the U.S. power grid to its limits, raising energy costs and prompting urgent upgrades in infrastructure and policy.
After spinning out from Intel, RealSense secures $50 million in funding to accelerate advancements in AI vision and robotics. Learn what this means for the future of automation and intelligent systems.
Filics has closed a €13.5M funding round to accelerate the development and international expansion of its autonomous warehouse robots, targeting efficient logistics and intralogistics innovation.
Amazon Web Services will debut its Agentic AI Marketplace next week, featuring Anthropic’s advanced AI. Learn how this move could reshape enterprise AI adoption and innovation.
Google Gemini AI introduces a photo-to-video feature, enabling users to create dynamic 8-second video clips with sound from images. Available for Ultra and Pro subscribers, this tool is powered by Veo 3 and brings new creative possibilities for content creators.
Varda Space has secured $187 million in funding to boost its space-based drug development program, targeting pharmaceutical breakthroughs and commercial launches by 2025.
Irish AI startup Oraion has raised €2.9 million in pre-seed funding to expand into the U.S. market and accelerate development of its enterprise automation platform.
NEURA Robotics and Hyundai are teaming up to deploy advanced cognitive robots in shipbuilding, aiming to solve labor shortages and set new standards in automation, safety, and productivity.
Discover how rapid AI advancements may soon replace traditional jobs, disrupt global economies, and drive the need for new income models like UBI.
UBTECH’s Walker S2 sets a new standard in robotics with autonomous battery swapping and continuous 24/7 operation. Explore what makes this humanoid robot a breakthrough in automation.
Dyson’s vertical strawberry farm in Lincolnshire uses robotics, giant rotating wheels, and sustainable engineering to produce 1.2 million strawberries annually, setting a new standard for high-tech agriculture in the UK.
futureTEKnow is focused on identifying and promoting creators, disruptors and innovators, and serving as a vital resource for those interested in the latest advancements in technology.
© 2025 All Rights Reserved.
